Tic Triggers Fatigue Stress Excitement and Illness

Share this post:

LinkedIn
Facebook
X
Reddit
WhatsApp
Print

Tic triggers are situations, body states or routines that can make tics more frequent, stronger or harder to manage for a period of time. Common trigger patterns include stress, fatigue, sleep loss, excitement, illness, body discomfort, school pressure, work demands and long periods of trying to suppress tics. A trigger does not mean tics are intentional. The National Institute of Neurological Disorders and Stroke (NINDS) states that tics may worsen with excitement or anxiety, and may improve during calm, focused activities.

Fast answer on tic triggers

Tic triggers can affect motor tics, vocal tics or both. You may notice more blinking, shoulder shrugging, head jerking, throat clearing, humming, sniffing or repeated words during certain times. You may also notice stronger urges before tics happen.

A trigger can be physical, emotional or environmental. Poor sleep, illness, pain, hunger, loud settings, public attention, transitions, exams, meetings and social pressure may all affect tic intensity for some people.

A trigger pattern is personal. One person may tic more during stress. Another may tic more after school, during excitement or while watching screens. Some tics rise with no clear pattern at all.

Tracking triggers can help, but it should not turn into blame. You are looking for practical clues that can support daily planning. You are not trying to prove that tics are caused by attitude, behavior or weak control.

Daily patterns that affect tics

Tics often change across the day. You may tic more in the morning, during school, after work or before bed. A child may suppress tics at school, then tic more at home. An adult may hold back tics during meetings, then feel drained later.

Tics can also change across weeks and months. A blinking tic may fade, then a shoulder tic may appear. A throat clearing tic may become less frequent, then a humming tic may start. This shifting pattern is common in tic disorders.

CDC describes tics as sudden twitches, movements or sounds that people do repeatedly. CDC also explains that people with tics cannot stop their body from doing these things in a simple voluntary way.  This is important when tracking triggers. A tic may change with setting or stress, but that does not make it fake.

Daily patterns to watch may include the following.

  • Time of day
  • Sleep quality
  • Stress level
  • Illness
  • Hunger
  • Screen time
  • Long sitting
  • Public attention
  • School or work pressure
  • Attempts to suppress tics
  • Pain or muscle strain

You do not need to track every tic. Short notes over one or two weeks can give enough detail for a care visit.

Stress and pressure

Stress is one of the most common tic trigger patterns. You may notice tics during exams, work deadlines, conflict, travel, crowded settings, public speaking or after a difficult day.

Stress can affect tics through body tension, attention, sleep disruption and the pressure to suppress symptoms. If you are trying hard not to tic, the effort itself can become tiring. Some people tic more later after holding symptoms in for a long time.

Stress does not mean the tic is a choice. It means the nervous system may react to pressure with more symptoms. NINDS lists excitement and anxiety as factors that may worsen tics. (NINDS) Mayo Clinic also states that tics can worsen when a person is ill, stressed, anxious, tired or excited.

Practical support for stress-linked tic flares may include the following.

  • Short breaks before symptoms build
  • Less pressure to suppress harmless tics
  • Calm routines before tests or meetings
  • A quiet place to reset
  • Breathing skills if anxiety rises
  • School or work support for high pressure tasks
  • Therapy support when fear of ticcing limits daily life

The aim is to reduce strain around symptoms. You do not need to remove every stressful event from life. You need a plan that helps you stay safe, supported and able to take part.

Fatigue and sleep loss

Fatigue can make tics harder to manage. Poor sleep can reduce your ability to hold back symptoms, think clearly, handle frustration and recover from tic flares.

A child who suppresses tics during school may come home tired and tic more. A teen may have stronger symptoms after late nights or early school days. An adult may notice tics after long shifts, travel, parenting strain or several nights of poor sleep.

Sleep loss can also make related symptoms harder. ADHD, anxiety, irritability, obsessive thoughts and pain may all feel worse when sleep is poor. These related symptoms can then add more pressure around tics.

Support for fatigue-linked tic flares may include the following.

  • A steadier bedtime when possible
  • Lower pressure routines before sleep
  • Breaks after school or work
  • Reduced late night screen strain when it affects sleep
  • Pain review if tics disturb rest
  • Clinician review when sleep problems are persistent

You should also ask for medical help if tics interfere with sleep, cause injury at night or appear with unusual sleep events, confusion or loss of awareness.

Excitement and transitions

Tics may increase during excitement. A child may tic more before a birthday party, sports event, trip or visit with friends. A teen may tic more before a performance, game or social event. An adult may tic more before a presentation, date, interview or major life event.

Excitement is a high energy state. The body may react with more tics even when the event is positive. This can confuse families because the person may tic more when they are happy.

Transitions can also trigger symptoms. Moving from home to school, class to class, work to home or screen time to bedtime can create pressure. Some people tic more when routines shift quickly.

Support for excitement and transitions may include the following.

  • Clear timing before changes
  • Short reset breaks between activities
  • Extra time before leaving home
  • A quiet option after crowded events
  • Calm language from adults
  • No punishment for tic increases during positive events

For children, avoid canceling every exciting activity because tics rise. Participation still matters. A better plan gives the child support before, during and after the event.

Illness and body discomfort

Illness can increase tics for some people. Colds, allergies, throat irritation, fever, pain, headaches, stomach discomfort and muscle soreness can all add body stress. A throat clearing tic may feel worse during a cold. A blinking tic may feel worse with eye irritation. A neck tic may feel harder when muscles are sore.

Mayo Clinic lists illness as one factor that may worsen tics. NINDS also notes that certain physical experiences can trigger or worsen tics.

Medical review is useful when a symptom could be a tic or a health problem. Sniffing can be a vocal tic, but it can also come from allergies or infection. Coughing can be a vocal tic, but it can also come from asthma, reflux or illness. Eye blinking can be a motor tic, but it can also relate to eye irritation or vision problems.

Seek prompt medical care if symptoms include breathing problems, wheezing, fever, severe headache, confusion, weakness, fainting, seizure like events, chest pain, swallowing problems or sudden severe change.

Body discomfort can also become a cycle. A tic causes soreness, then soreness increases attention to that body area, then the urge feels stronger. Pain care, physical therapy, tic treatment and rest may all be part of the plan when this happens.

School and work demands

School and work can create tic pressure because both often involve sitting still, staying quiet, focusing for long periods and managing social reactions. These demands can increase symptoms or make symptoms harder to tolerate.

At school, tic triggers may include tests, reading aloud, handwriting, quiet classrooms, peer attention, strict discipline, transitions and fear of being teased. CDC notes that tics can affect school because they may make reading or writing hard, distract the child or lead to teasing and bullying.

Helpful school support may include the following.

  • Brief movement breaks
  • Permission to leave class when needed
  • Quiet testing space
  • Extra time when tics interrupt work
  • Typed assignments
  • Staff education
  • A plan for bullying or filming
  • A discreet signal between student and teacher

At work, tic triggers may include meetings, calls, presentations, shared quiet spaces, deadlines, long computer sessions, customer contact and public speaking. Work support may include breaks, seating choice, written follow up after meetings, private space during tic flares, camera flexibility during virtual meetings and ergonomic changes when motor tics cause pain.

Support should focus on function. If the tic affects writing, address writing. If the tic affects speech, address calls or presentations. If the tic causes pain, address pain and posture.

Tracking without blame

Tracking can help you find patterns, but it should stay calm. The purpose is to support care and planning. It should not turn into constant checking, criticism or self blame.

You can track for one or two weeks before a clinician visit. Keep notes short.

Useful items to track include the following.

  • Main motor tics
  • Main vocal tics
  • Time of day
  • Sleep quality
  • Stress level
  • Illness or pain
  • School or work demands
  • Public attention
  • Attempts to suppress tics
  • Tic flares after high pressure settings
  • Related ADHD, OCD or anxiety symptoms
  • Safety concerns

For a child, parents should avoid pointing out every tic. A child can feel watched and embarrassed. Instead, note patterns quietly and ask about pain, teasing, fatigue or school problems.

For teens, tracking should respect privacy. Ask before recording a tic. Let the teen help decide what gets shared with the clinician or school.

For adults, track task impact. Note if tics affect driving, meetings, typing, tools, public settings, sleep, pain or relationships. This helps shape a care plan.

What to do during a tic flare-up

A tic flare-up is a period when tics become stronger, more frequent or harder to manage. The first step is to reduce pressure.

You can pause the current task, move to a quieter space, take a short break, stretch gently if safe, drink water or use a coping skill taught by a clinician. If you are with a child, stay calm and avoid repeated correction.

During a flare-up, ask practical questions.

  • Is anything painful
  • Is the person safe
  • Is there a way to reduce pressure
  • Is a break needed
  • Is school or work support needed
  • Has illness, fatigue or stress been present
  • Is this pattern new or severe

A flare-up does not mean the person has failed. It also does not mean every activity must stop. Support should match the level of risk and distress.

Seek clinical care if flare-ups cause injury, breathing problems, inability to eat or drink, severe distress, self hitting, school removal, work loss or major social avoidance.

Care team discussion points

A clinician can help you decide when tic triggers need monitoring, behavioral care, medication review or support for related conditions.

Bring clear notes to the visit. Your clinician may ask about tic type, age of onset, duration, pain, school or work impact, sleep, stress, illness, medications and related symptoms.

You may ask the following.

  • Do these symptoms fit a tic disorder
  • Are the trigger patterns typical
  • Do tics need treatment now
  • Is CBIT appropriate
  • Should medication be considered
  • Could ADHD, OCD or anxiety be affecting tic flares
  • What school or work support is appropriate
  • What symptoms should prompt urgent care
  • How should we track symptoms without pressure

The American Academy of Neurology (AAN) guideline page says its treatment recommendations for Tourette syndrome and chronic tic disorders were reaffirmed on April 7, 2025. The guideline includes watchful waiting when tics do not cause functional impairment and CBIT as an initial treatment option for people with access to it.

CBIT and trigger patterns

CBIT can help some people respond to tics and trigger patterns. CDC describes CBIT as a behavioral treatment that helps a person become aware of tics, use competing responses and make changes to situations that can make tics worse.

In CBIT, you may identify where a tic happens, what the urge feels like and which settings make it harder. Then you practice a competing response when the urge appears. You may also adjust routines that add pressure.

CBIT should be taught by a trained provider. It does not mean tics are voluntary. It means you can learn skills that may reduce how tics affect your life.

Related conditions that can affect tic flares

ADHD, OCD, anxiety, mood concerns, sleep problems and learning issues can affect tic flares. CDC notes that Tourette syndrome often occurs with other conditions such as ADHD and OCD.

ADHD can make school or work demands harder. A child may struggle with homework, class transitions or long sitting. An adult may struggle with deadlines, meetings or task switching.

OCD can add intrusive thoughts, repeated behaviors and distress. Some compulsions can look like complex tics. A clinician can help separate the patterns.

Anxiety can make public settings harder. Fear of ticcing can increase pressure, then symptoms may rise. Therapy and practical planning may help when anxiety limits daily life.

Sleep problems can increase fatigue and reduce coping capacity. If sleep is poor, the tic plan should address sleep as part of care.

Research context

Research on tic triggers can help clinicians learn how sleep, stress, emotion, attention, illness and settings affect symptoms. Better research can also improve behavioral care, school planning and support for related conditions.

Regulated psychedelic research has added useful scientific work on brain networks, neuroplasticity and mental health models. Psilocybin is not an established treatment for tic triggers, Tourette syndrome or tic disorders. Any future tic related research should use clear diagnosis, validated tic measures, safety review and careful screening for ADHD, OCD, anxiety and mood symptoms.

Research note

As you review tic triggers, daily patterns and future research questions, we at Rose Hill Life Sciences approach this topic through science led education. Our work focuses on psychedelic research, production and study of Psilocybe cubensis, the intersection of science and therapeutic integration and our Massachusetts research work, while tic management and treatment decisions should remain with qualified healthcare professionals.

Conclusion

Start with one or two weeks of calm tracking. Look for patterns involving stress, fatigue, excitement, illness, school, work, public attention and suppression. Track pain, safety issues and daily limits too.

If tics are mild and do not disrupt life, ask a clinician about monitoring. If tics cause pain, injury, school issues, work problems, distress or social strain, ask about CBIT, medication review, school or work support and related condition screening.

For children, reduce correction and protect them from teasing. For teens, respect privacy and include them in planning. For adults, focus on work, pain, public settings, sleep and relationships.

Tic triggers are clues for support. They should help you plan care without blame.

Disclaimer: The information in this article is for educational and informational purposes only and does not constitute medical advice.

You May Also Like

Adam Goodman

Advisor

Adam is a seasoned entrepreneur with a wealth of experience in spearheading real estate development and management endeavors. His focus primarily lies in land development, where he orchestrates the intricate tapestry of planning and zoning entitlements, while meticulously overseeing all facets of engineering and architectural design, leasing, construction, and financing.

With a national reach spanning 23 states and encompassing over 250 properties, totaling more than 6 million square feet, Adam’s proficiency in navigating the complexities of the industry is evident.

Beyond real estate, Adam’s endeavors extend into the realm of alternative investments, boasting successful ventures in healthcare, professional sports franchises, financial services, diverse agricultural platforms, and the stewardship of local restaurants.

 

Rotem Petranker, PhD, Psychology

Psychedelic Researcher

Rotem Petranker is a psychedelics researcher with a particular emphasis on microdosing, therapy, research methods and research ethics. He earned his BSc from the University of Toronto, his Master’s degree from York University, and his PhD from McMaster University.

As part of my research, I have gained extensive expertise in navigating the regulatory landscapes of Health Canada and the FDA and a strong background in designing rigorous clinical trial research methodologies. 

I founded the Canadian Centre for Psychedelic Science in 2018, established the Psychedelic Science Research Program at the University of Toronto in 2019, and, more recently, ran the largest clinical trial to date on the effectiveness of microdosing psilocybin for Major Depressive Disorders. I have published many papers on microdosing, including some of the largest samples in the literature and some that have set standards for performing psychedelic research.

Kevin Bourke

Chief Commercial Officer

Kevin Bourke is a dynamic executive and strategic planner whose career spans over two decades of crafting and elevating world-class Jamaican brands and transformational experiences on the global stage. With a keen understanding of culture, identity, and international markets, he has played a pivotal role in shaping some of Jamaica’s most iconic names — including Appleton Estate Rum, Chris Blackwell’s Rum, and Usain Bolt’s Tracks & Records — bringing them from local roots to international acclaim. His leadership and vision have also been instrumental in major cultural movements such as Fiction and the internationally recognized TmrwTday Wellness Festival.

An innovator at heart, Mr. Bourke seamlessly blends brand strategy with deep cultural resonance. His ability to connect with diverse audiences has established these brands not only as commercial successes but as symbolic ambassadors of Jamaican excellence, fortifying the island’s influence in beverage, music, lifestyle, and experiential sectors.

In recent years, Kevin has steered his strategic acumen toward the cutting-edge psilocybin and wellness industry, becoming a co-founder and Chief Marketing and Branding Officer of Rose Hill, Jamaica’s leading cultivator, exporter, and innovator of psilocybin products and experiences. Through ventures like ONE Retreats, he has helped craft safe, guided psychedelic-assisted healing programs that attract participants from around the world seeking deep personal transformation, including military veterans and international wellness seekers.

Kevin’s impact extends beyond business into industry shaping and policy, as he sits on the Jamaica Psilocybin Mushroom Industry Technical Committee (under the Bureau of Standards) — a pivotal body that is formalizing guidelines and regulatory standards for the emerging legal psilocybin sector in Jamaica. His presence on this committee underscores his leadership role in ensuring the industry’s integrity, safety, and sustainable growth.

Highly regarded for his extensive network throughout Jamaica and internationally, Kevin remains passionately committed to advancing ethical, high-integrity product development and customer-centric experiences at every level. His dedication is driven not only by professional achievement but by a deep vision for human well-being, cultural celebration, and the global evolution of plant-based healing.

Jama Pitman

Regulatory Strategy

Jama Pitman is a seasoned biopharmaceutical executive with extensive expertise in global drug development and commercialization. With over two decades of experience, she has contributed to the development of groundbreaking therapies across oncology, rare diseases, and antivirals. As a strategic leader, she has successfully transitioned companies from private to public markets, navigated complex M&A transactions, and driven innovative drug approvals.

Jama has held executive roles in leading organizations, including Deciphera Pharmaceuticals, where she played a pivotal role in scaling operations from a small, privately held biotech company to a global, multi-product company acquired for $2.4 billion. She brings exceptional skills in regulatory affairs, portfolio management, quality assurance, and clinical operations, longside a proven track record of fostering inclusivity and mentorship within her teams.

Currently, as the founder of JP BioPharma Consulting, Jama advises biopharma and tech companies on accelerating drug development and achieving corporate goals. Her collaborative and forward-thinking approach aligns seamlessly with Rose Hill’s mission to advance transformative therapies in mental health and beyond.

Education: B.Sc. in Microbiology, University of New Hampshire.

Notable Achievements: Contributed to the development of multiple FDA-approved therapies, including QINLOCK® for gastrointestinal stromal tumors.

Domenic Suppa

Chief Operating Officer

Domenic is co-founder and the Operations Chief of Rose Hill Health Holdings.

He has been working as a Cannabis technology and operations veteran with more than 11 years’ experience as a senior executive in an operationally complex, and highly regulated industry.

His introduction and entrance into the Cannabis sector started in 2010 with a seed investment into a Denver-based vertically integrated cannabis company called, Evolab. He served as C.O.O. for 5 years from 2013-2018, through the eventual acquisition by Harvest Health and Recreation (HARV: CSE).

Domenic moved on to be acting COO of the manufacturing division for Supreme Cannabis (CSE: FIRE) and supported the acquisition of BLISSCO (CSE: BLISS, a BC-based cannabis manufacturer). Domenic has worked with high-profile national cannabis brands including KKE, and Monogram, and retail brands in MA Native Sun, Terps, and Tilt. Domenic is a proven leader and team builder; his previous experiences have all been with early-stage and growth equity enterprises.

He has refined and evolved his leadership roles, including his team-building skills. He is a value creator. Domenic is a firm believer in training and continuous development. He excels in employing practices, tools, and methodologies designed to achieve maximum process efficiency while minimizing waste and delays.

 

Burton J. Tabaac

Clinical Development

Dr. Burton J. Tabaac, MD, FAHA, brings a wealth of expertise in neurology and stroke rehabilitation to Rose Hill. As an Associate Professor and Section Chief of Neurology at The University of Nevada’s Reno School of Medicine, and Medical Director of Stroke at Carson Tahoe Health, Dr. Tabaac has been at the forefront of innovative neurological treatments.

A graduate of the prestigious cerebrovascular neurology fellowship program at The Johns Hopkins University Hospital, Dr. Tabaac’s accolades include being a three-time recipient of The Arnold P. Gold Foundation’s Humanism and Excellence in Teaching Award and induction into the Alpha Omega Alpha Honor Medical Society.

He recently published an eight-part paper in the American Journal of Therapeutics reviewing psychedelics as therapeutics for primary care clinicians. Dr. Tabaac’s groundbreaking research focuses on the application of psychedelics in brain injury and stroke rehabilitation.

Dr. Tabaac was recently appointed by the Governor of Nevada to serve as a member of the state’s Psychedelic Medicines Working Group, which provides expertise and testimony relating to the therapeutic use of entheogens.

As the host of The Zero Hour Podcast, he engages with leading experts in psychedelic research. His commitment to advancing the field was further highlighted in his 2022 TEDx talk at UCLA, “Mental Health Meets Psychedelics.”

“Joining Rose Hill’s advisory team presents an exciting opportunity to further explore the potential of psilocybin in neurological recovery,” said Dr. Tabaac.

“The company’s commitment to ethical cultivation and research aligns perfectly with my vision for advancing patient care through innovative therapies. I’m eager to bring my expertise to Rose Hill and contribute to the evolving landscape of psychedelic medicine.”

Charles Lazarus

Chief Executive Office

Mr. Lazarus boasts over 16 years of extensive expertise in psilocybin and cannabis, focusing on genetic development, cultivation, extraction, and operations logistics. Notably, he recently achieved a milestone by cultivating and delivering the largest legal shipment of premium psilocybin globally.

As an accomplished owner/operator, Mr. Lazarus has successfully managed multiple farming and harvesting businesses, earning commendations for his unwavering commitment to quality and impressive output volumes. Since 2015, he has been actively involved in producing proprietary psilocybin genetics and cultivation solutions tailored for the Jamaican market and large research and development clients.

His contributions span various aspects, including genetic development, cultivation, extraction, harvest, and logistics. Additionally, Mr. Lazarus owned and operated Island Fresh Ltd., a venture that played a pivotal role in exporting fresh fruit, ground provisions, and promoting brand Jamaica to the English market. Under his leadership, Island Fresh Ltd. achieved the highest volume from Jamaica for three consecutive years.

Mr. Lazarus’s extensive experience also includes serving as the Harvest Manager for cannabis grow operations in California from 2013 to 2017, further solidifying his comprehensive knowledge in the cannabis industry.